ArticleOncology letters2024

Efficacy and side effects of pembrolizumab plus chemotherapy vs. chemotherapy alone in patients with advanced gastric or gastroesophageal junction adenocarcinoma: A meta‑analysis.

Jinquan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.